"Designing Growth Strategies is in our DNA"

U.S. Bone Graft Substitutes Market Size, Share & Industry Analysis, By Type (Allograft, Demineralized Bone Matrix (DBM), Synthetic {Polymer, and Ceramic [Hydroxyapatite, Beta TCP, and Others]}, and Xenograft), By Application (Spinal Fusion, Joint Reconstruction, Foot & Ankle, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Forecast, 2024-2032

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI109191

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology of Clinical Indications in the U.S.
    2. Profiles of Key Products Available in Bone Graft Substitutes Market
    3. Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
    4. New Product Launches
    5. Impact of COVID-19 on Bone Graft Substitutes Market
  5. U.S. Bone Graft Substitutes Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Allograft
      2. Demineralized Bone Matrix (DBM)
      3. Synthetic
        1. Polymers
        2. Ceramic
          1. Hydroxyapatite
          2. Beta TCP
          3. Others
      4. Xenograft
    2. Market Analysis, Insights and Forecast – By Application
      1. Spinal Fusion
      2. Joint Reconstruction
      3. Foot & Ankle
      4. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Medtronic
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. DePuy Synthes Companies (Johnson & Johnson Services, Inc.)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Stryker
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Zimmer Biomet
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Smith & Nephew plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. SeaSpine
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. AlloSource
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Bioventus
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. MTF Biologics
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Orthofix Holdings, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology of Clinical Indications in the U.S.
    2. Profiles of Key Products Available in Bone Graft Substitutes Market
    3. Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
    4. New Product Launches
    5. Impact of COVID-19 on Bone Graft Substitutes Market
  5. U.S. Bone Graft Substitutes Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Allograft
      2. Demineralized Bone Matrix (DBM)
      3. Synthetic
        1. Polymers
        2. Ceramic
          1. Hydroxyapatite
          2. Beta TCP
          3. Others
      4. Xenograft
    2. Market Analysis, Insights and Forecast – By Application
      1. Spinal Fusion
      2. Joint Reconstruction
      3. Foot & Ankle
      4. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Medtronic
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. DePuy Synthes Companies (Johnson & Johnson Services, Inc.)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Stryker
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Zimmer Biomet
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Smith & Nephew plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. SeaSpine
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. AlloSource
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Bioventus
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. MTF Biologics
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Orthofix Holdings, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Table 01: U.S. Bone Graft Substitutes Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 02: U.S. Bone Graft Substitutes Market Revenue (USD billion) Forecast, By Synthetic, 2019–2032

Table 03: U.S. Bone Graft Substitutes Market Revenue (USD billion) Forecast, By Ceramic, 2019–2032

Table 04: U.S. Bone Graft Substitutes Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 05: U.S. Bone Graft Substitutes Market Revenue (USD billion) Forecast, By End-user, 2019–2032

Figure 01: U.S. Bone Graft Substitutes Market Revenue Breakdown (USD billion, %) by Application, 2023 & 2032

Figure 02: U.S. Bone Graft Substitutes Market Value Share (%), By Type, 2023 & 2032

Figure 03: U.S. Bone Graft Substitutes Market Value Share (%), By Application, 2023 & 2032

Figure 04: U.S. Bone Graft Substitutes Market Value Share (%), By End-user, 2023 & 2032

Figure 05: U.S. Bone Graft Substitutes Market Share Analysis (%), By Company, 2023

  • 2019-2032
  • 2023
  • 2019-2022
  • 70
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann